Perspective Therapeutics CATX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Perspective Therapeutics’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's pre-tax income?
- Perspective Therapeutics (CATX) reported pre-tax income of -$38.28M in Q4 2025.
- How has Perspective Therapeutics's pre-tax income changed year-over-year?
- Perspective Therapeutics's pre-tax income increased by 9.4% year-over-year, from -$42.27M to -$38.28M.
- What is the long-term trend for Perspective Therapeutics's pre-tax income?
- Over 2 years (2023 to 2025), Perspective Therapeutics's pre-tax income has grown at a 61.4% compound annual growth rate (CAGR), from -$40.11M to -$104.43M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.